AMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AMN Healthcare Services Inc is not a strong buy for a beginner, long-term investor at this time. The stock exhibits bearish technical trends, weak financial performance, and lacks strong positive catalysts. While analysts have slightly raised price targets, the sentiment remains mixed, and there are no significant trading signals or influential buying activity to support a buy decision.
The stock shows bearish moving averages (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. RSI is neutral at 44.929, and MACD is slightly positive but contracting. The stock price is near its support level (S1: 17.757), but overall technical indicators do not suggest a strong buy signal.
Analysts have slightly raised price targets, citing potential recovery in 2027 and the company's ability to handle large-scale labor disruptions. Retention of the Kaiser contract is seen as a positive factor.
The stock price has declined in both pre-market (-1.58%) and regular market (-2.58%). Financial performance in the latest quarter shows significant YoY declines in net income (-95.90%) and EPS (-95.92%), along with a drop in gross margin (-12.00%). Options data reflects bearish sentiment, and there are no recent congress trading data or significant insider/hedge fund activity.
In Q4 2025, revenue increased by 1.84% YoY to $748.2M. However, net income dropped significantly to -$7.7M (-95.90% YoY), EPS fell to -0.2 (-95.92% YoY), and gross margin declined to 21.42% (-12.00% YoY). These figures indicate weak financial health.
Analysts have raised price targets slightly (e.g., Citizens to $24, Baird to $23, UBS to $19.50), but sentiment remains mixed with Neutral ratings from Baird and UBS. Analysts highlight potential recovery in 2027 but note near-term financial challenges.
